| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michiel F Dirkx, Hanneke E M den Ouden, Esther Aarts, Monique H M Timmer, Bastiaan R Bloem, Ivan Toni, Rick C Helmic. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus. Brain : a journal of neurology. vol 140. issue 3. 2017-05-29. PMID:28073788. |
dopamine controls parkinson's tremor by inhibiting the cerebellar thalamus. |
2017-05-29 |
2023-08-13 |
Not clear |
| Michiel F Dirkx, Hanneke E M den Ouden, Esther Aarts, Monique H M Timmer, Bastiaan R Bloem, Ivan Toni, Rick C Helmic. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus. Brain : a journal of neurology. vol 140. issue 3. 2017-05-29. PMID:28073788. |
although parkinson's disease is characterized by dopamine depletion in the basal ganglia, the dopaminergic basis of resting tremor remains unclear: dopaminergic medication reduces tremor in some patients, but many patients have a dopamine-resistant tremor. |
2017-05-29 |
2023-08-13 |
Not clear |
| Michiel F Dirkx, Hanneke E M den Ouden, Esther Aarts, Monique H M Timmer, Bastiaan R Bloem, Ivan Toni, Rick C Helmic. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus. Brain : a journal of neurology. vol 140. issue 3. 2017-05-29. PMID:28073788. |
building on a recently developed cerebral model of parkinson's tremor, we tested the effect of dopamine on cerebral activity associated with the onset of tremor episodes (in the basal ganglia) and with tremor amplitude (in the cerebello-thalamo-cortical circuit). |
2017-05-29 |
2023-08-13 |
Not clear |
| Michiel F Dirkx, Hanneke E M den Ouden, Esther Aarts, Monique H M Timmer, Bastiaan R Bloem, Ivan Toni, Rick C Helmic. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus. Brain : a journal of neurology. vol 140. issue 3. 2017-05-29. PMID:28073788. |
crucially, the magnitude of thalamic self-inhibition predicted the clinical dopamine response of tremor. |
2017-05-29 |
2023-08-13 |
Not clear |
| Michiel F Dirkx, Hanneke E M den Ouden, Esther Aarts, Monique H M Timmer, Bastiaan R Bloem, Ivan Toni, Rick C Helmic. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus. Brain : a journal of neurology. vol 140. issue 3. 2017-05-29. PMID:28073788. |
dopamine reduces resting tremor by potentiating inhibitory mechanisms in a cerebellar nucleus of the thalamus (ventral intermediate nucleus). |
2017-05-29 |
2023-08-13 |
Not clear |
| Sherifa A Hamed, Mostafa M Abdella. The relationship between valproate induced tremors and circulating neurotransmitters: a preliminary study. The International journal of neuroscience. vol 127. issue 3. 2017-03-27. PMID:27161592. |
we hypothesize that vpa-induced tremors may be related to the disturbances in dopamine (da) and catecholamines (norepinephrine (ne) and epinephrine (e)) concentrations (which are also involved in vpa anticonvulsant effect). |
2017-03-27 |
2023-08-13 |
Not clear |
| Barbara Kosmowska, Jadwiga Wardas, Urszula Głowacka, Subramaniam Ananthan, Krystyna Ossowsk. Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats. CNS neuroscience & therapeutics. vol 22. issue 1. 2016-10-17. PMID:26459182. |
the aim of the study was to examine the effects of preferential agonists of dopamine d3 receptors: pramipexole and 7-oh-dpat on the harmaline-induced tremor in rats (a model of essential tremor, et). |
2016-10-17 |
2023-08-13 |
rat |
| Samantha J Podurgiel, Samantha E Yohn, Kristina Dortche, Merce Correa, John D Salamon. The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine. Behavioural brain research. vol 298. issue Pt B. 2016-09-20. PMID:26590367. |
the mao-b inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the vmat-2 inhibitor tetrabenazine. |
2016-09-20 |
2023-08-13 |
mouse |
| Nicoletta Schintu, Xiaoqun Zhang, Alexandra Alvarsson, Roberta Marongiu, Michael G Kaplitt, Paul Greengard, Per Svenningsso. p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. vol 113. issue 5. 2016-08-08. PMID:26787846. |
in contrast, mice lacking p11 in dopamine d1r-containing neurons exhibit tremor and rotational responses toward l-dopa, but develop less dyskinesia. |
2016-08-08 |
2023-08-13 |
mouse |
| Davide Ferrazzoli, Adrian Carter, Fatma S Ustun, Grazia Palamara, Paola Ortelli, Roberto Maestri, Murat Yücel, Giuseppe Frazzitt. Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson's Disease: Implications for Rehabilitation. Frontiers in behavioral neuroscience. vol 10. 2016-07-06. PMID:27378872. |
dopamine replacement therapy (drt) compensates for the lack of dopamine, representing the standard treatment for different motor symptoms of pd (such as rigidity, bradykinesia and resting tremor). |
2016-07-06 |
2023-08-13 |
Not clear |
| Samantha J Podurgiel, Meredith N Milligan, Samantha E Yohn, Laura J Purcell, Hector M Contreras-Mora, Mercè Correa, John D Salamon. Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 40. issue 9. 2016-04-26. PMID:25759301. |
fluoxetine administration exacerbates oral tremor and striatal dopamine depletion in a rodent pharmacological model of parkinsonism. |
2016-04-26 |
2023-08-13 |
rat |
| Hua-Guang Zheng, Rong Zhang, Xin Li, Fang-Fei Li, Ya-Chen Wang, Xue-Mei Wang, Ling-Long Lu, Tao Fen. Heterogeneity of Monosymptomatic Resting Tremor in a Prospective Study: Clinical Features, Electrophysiological Test, and Dopamine Transporter Positron Emission Tomography. Chinese medical journal. vol 128. issue 13. 2016-03-15. PMID:26112718. |
heterogeneity of monosymptomatic resting tremor in a prospective study: clinical features, electrophysiological test, and dopamine transporter positron emission tomography. |
2016-03-15 |
2023-08-13 |
Not clear |
| Carlos Juri, Pedro Chana, Vasko Kramer, Rossana Pruzzo, Horacio Amaral, Patrick J Riss, Frank Rösc. Imaging Nigrostriatal Dopaminergic Deficit in Holmes Tremor with 18F-PR04.MZ-PET/CT. Clinical nuclear medicine. vol 40. issue 9. 2016-03-04. PMID:26204203. |
we herein report an interesting case of holmes tremor studied with pet and f-pr04.mz, a new high-affinity radioligand for dopamine transporters, currently under investigation at our center. |
2016-03-04 |
2023-08-13 |
Not clear |
| Go Koganemaru, Hiroshi Abe, Aki Kuramashi, Kosuke Ebihara, Hisae Matsuo, Hideki Funahashi, Kazuya Yasuda, Tetsuya Ikeda, Toshikazu Nishimori, Yasushi Ishid. Effects of cabergoline and rotigotine on tacrine-induced tremulous jaw movements in rats. Pharmacology, biochemistry, and behavior. vol 126. 2015-11-09. PMID:25265240. |
we examined the effects of two dopamine agonists, cabergoline and rotigotine, on tacrine-induced tremor and c-fos expression in rats. |
2015-11-09 |
2023-08-13 |
rat |
| Valtteri Kaasinen, Maija Kinos, Juho Joutsa, Marko Seppänen, Tommi Nopone. Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease. European journal of nuclear medicine and molecular imaging. vol 41. issue 10. 2015-06-05. PMID:24867256. |
differences in striatal dopamine transporter density between tremor dominant and non-tremor parkinson's disease. |
2015-06-05 |
2023-08-13 |
Not clear |
| Valtteri Kaasinen, Maija Kinos, Juho Joutsa, Marko Seppänen, Tommi Nopone. Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease. European journal of nuclear medicine and molecular imaging. vol 41. issue 10. 2015-06-05. PMID:24867256. |
the present study investigated striatal dopamine transporter (dat) binding characteristics in a large sample of patients with and without tremor. |
2015-06-05 |
2023-08-13 |
Not clear |
| Jiro Fukae, Chikashi Fukaya, Hideki Oshima, Kenji Ishii, Yoshio Tsuboi, Yoichi Katayama, Nobutaka Hattor. [Successful treatment with bilateral deep brain stimulation of the subthalamic nucleus for benign tremulous parkinsonism]. Rinsho shinkeigaku = Clinical neurology. vol 54. issue 6. 2015-04-13. PMID:24990837. |
although he was diagnosed as having benign tremulous parkinsonism (btp), anti-parkinsonian medications, including anti-cholinergic agent, dopamine agonist and l-dopa, were not effective for his tremor. |
2015-04-13 |
2023-08-13 |
Not clear |
| Drugs for Parkinson's disease. Treatment guidelines from the Medical Letter. vol 11. issue 135. 2014-06-02. PMID:24165688. |
dopamine agonists, the next most effective class of drugs, can be used alone before the introduction of levodopa or as an adjunct to levodopa.addition of a peripherally-acting comt inhibitor or an mao-b inhibitor to levodopa can reduce motor fluctuations in patients with advanced disease.amantadine may have mild symptomatic benefit and can decrease levodopa-induced dyskinesias.anticholinergics are rarely used because of their adverse effects, but can be a useful addition to levodopa for control of tremor and drooling.subcutaneous apomorphine should be available for rescue use in patients with 'off' episodes. |
2014-06-02 |
2023-08-12 |
Not clear |
| Ji-Hye Yang, Sung-Woo Chung, Joong-Seok Ki. Action tremor associated with lamotrigine monotherapy. Journal of movement disorders. vol 3. issue 1. 2014-05-28. PMID:24868374. |
based on the temporal relationship, it is conceivable that lamotrigine increases serotonin transmission or affects basal ganglia dopamine activity, thereby causing the tremor. |
2014-05-28 |
2023-08-13 |
Not clear |
| Shagufta Khan, Ghulam Abbas, Fahad Shabbir Ahmed, Attaur Rahman, Ahsana Da. Effect of dichloromethane fraction of Areca catechu nut on monoamines associated behaviors and tyramine pressor sensitivity in rodents. Pakistan journal of pharmaceutical sciences. vol 27. issue 2. 2014-05-12. PMID:24577919. |
the current study was aimed at investigating the effect of areca catechu nut dichloromethane fraction (7 mg/kg) on monoamines (serotonin and dopamine) modulation (5-hydroxytryptophan-induced tremors and phenylethylamine-induced stereotypes) and its interaction with tyramine (cheese effect). |
2014-05-12 |
2023-08-12 |
Not clear |